EGFR upregulates inflammatory and proliferative responses in human lung adenocarcinoma cell line (A549), induced by lower dose of cadmium chloride

Overcoming resistance to tyrosine kinase inhibitors: Lessons learned from cancer cells treated with EGFR antagonists

(2011) Brent N. Rexer et al.   CELL CYCLE

Cadmium induces lung inflammation independent of lung cell proliferation: a molecular approach

(2009) Subhadip Kundu et al.   Journal of Inflammation-London

Biphasic effect of cadmium on cell proliferation in human embryo lung fibroblast cells and its molecular mechanism

(2009) Gaofeng Jiang et al.   TOXICOLOGY IN VITRO

Transcriptome Analyses in Normal Prostate Epithelial Cells Exposed to Low-Dose Cadmium: Oncogenic and Immunomodulations Involving the Action of Tumor Necrosis Factor

(2008) Shlomo Bakshi et al.   ENVIRONMENTAL HEALTH PERSPECTIVES

An epidermal growth factor inhibitor, Gefitinib, induces apoptosis through a p53-dependent upregulation of pro-apoptotic molecules and downregulation of anti-apoptotic molecules in human lung adenocarcinoma A549 cells

(2008) Gee-Chen Chang et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Hormesis Predicts Low-Dose Responses Better Than Threshold Models

(2008) Edward J. Calabrese et al.   INTERNATIONAL JOURNAL OF TOXICOLOGY

Epidermal Growth Factor receptor (EGFR) regulates mechanical ventilation–induced lung injury in mice

(2008) Alexis Bierman et al.   Translational Research

Hormesis defined

(2007) Mark P. Mattson   AGEING RESEARCH REVIEWS